Invention Grant
US08269012B2 Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
有权
c-met蛋白激酶的氨基吡唑三唑并噻二唑抑制剂
- Patent Title: Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
- Patent Title (中): c-met蛋白激酶的氨基吡唑三唑并噻二唑抑制剂
-
Application No.: US12788608Application Date: 2010-05-27
-
Publication No.: US08269012B2Publication Date: 2012-09-18
- Inventor: David Lauffer , Pan Li , Kira McGinty
- Applicant: David Lauffer , Pan Li , Kira McGinty
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Daniel A. Pearson
- Main IPC: C07D215/12
- IPC: C07D215/12 ; A61K31/47
Abstract:
The present invention relates to compounds of formula I, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.
Public/Granted literature
- US20110124684A1 AMINOPYRAZOLE TRIAZOLOTHIADIAZOLE INHIBITORS OF C-MET PROTIEN KINASE Public/Granted day:2011-05-26
Information query
